Source: BioPortfolio

Parion Sciences: Parion Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 16102018 Prices from USD $250

SummaryParion Sciences Inc Parion Sciences is a development stage company that provides research development and commercialization of treatments to improve patient's innate mucosal surface defenses. The company's pipeline products include P1037 a clinical ...

Read full article »
Parion Sciences's Competitors | Parion Sciences's News | Parion Sciences's Financials
Stay up-to-date with the latest news on Parion Sciences
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Paul Boucher's photo - President & CEO of Parion Sciences

President & CEO

Paul Boucher

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Parion Sciences